جست‌وجوی استاد و پژوهشگر

Nona Farbehiمشاهده پروفایل

مدرس

• Microfluidics and nanofluidics
• Regenerative medicine (incl. stem cells)
• Bioinformatics and computational biology
• +۷ مورد دیگر

Dr. Nona Farbehi is a Lecturer at the Graduate School of Biomedical Engineering, UNSW Sydney, and an Honorary Visiting Scientist at the Garvan Institute. She holds a PhD from UNSW, supported by the IPRS Scholarship and Stem Cells Australia, and conducted post-doctoral research in Prof. Joseph Powell’s lab. Her interdisciplinary research focuses on single-cell genomics, microfluidic devices, and biomaterials, addressing cardiovascular diseases and regenerative medicine. She leads grants totaling over $1.2 million, including UNSW Engineering Infrastructure Fund and NSW Health Cardiovascular Research grants. Dr. Farbehi has supervised multiple PhD, Master’s, and Honours students and is actively involved in developing novel biomaterials and genomic technologies. Education: PhD (Biomedical Engineering, UNSW, 2018), Master’s (Amir Kabir University, 2011), Bachelor’s (Islamic Azad University, 2009). Research Interests: Single-cell transcriptomics, CRISPR interference, biomaterials, medical implants, and cardiac disease. Her work integrates bioinformatics tools and microfluidics to study cellular phenotypes and design therapeutic materials. Awards: Multiple travel awards, poster prizes, and recognition for her PhD thesis. Her research bridges engineering and medicine to advance regenerative therapies and precision diagnostics. Grants: Includes equipment funding for material testing and collaborative projects on aortic valve replacement materials. She collaborates nationally and internationally through platforms like the Garvan Weisman Centre for Cellular Genomics. Labs/Teams: Active in the Garvan Institute and UNSW’s biomedical engineering labs, focusing on stem cell technology and cardiac research.

• Nuclear Receptors
• Hormonal Carcinogenesis
• Androgen Receptor Research
• +۴ مورد دیگر

Professor Wayne Tilley is the Director of the Dame Roma Mitchell Cancer Research Laboratories (DRMCRL) at the University of Adelaide, affiliated with the Adelaide Medical School and the Faculty of Health and Medical Sciences. His research spans 40 years, focusing on nuclear receptors and hormonal carcinogenesis, particularly androgen receptor (AR) and progesterone receptor (PR) signaling in breast and prostate cancers. Eligible to supervise Masters and PhD students Over 225 peer-reviewed publications Research Themes: He investigates mechanisms of sex hormone signaling and resistance to hormonal therapies, pioneering the discovery of AR as a tumor suppressor in ER-positive breast cancer and PR-mediated inhibition of ER activity. His lab leverages patient-derived models (PDEs, PDXs) and genomic technologies to develop novel therapies targeting AR and PR in hormone-driven cancers. Publication Trends: Recent work emphasizes CDK9 inhibition in oncogenic transcription, SARMs for AR reprogramming, and cross-talk between hormone receptors. Studies also explore fatty acid metabolism in prostate cancer and computational tools for pathway analysis. Scientific Recognition: Received Endocrine Society of Australia Senior Plenary Award (2016) Chair of 2015 Gordon Research Conference Co-chair of 2022 Fusion Nuclear Receptor Meeting Leadership & Collaboration: Convenes the International PacRim Breast and Prostate Cancer Meeting Series. Collaborates with clinicians, medicinal chemists (e.g., Prof. Shudong Wang), and multidisciplinary teams to translate findings into clinical trials, including four trials of AR and PR activation in ER-driven disease. Laboratory Focus: DRMCRL integrates basic and translational research, using preclinical models and proteomic/genomic databases to decode hormone receptor dynamics. Current projects seek bioinformatics students for cross-disciplinary analysis of large datasets.

Ryan Listerمشاهده پروفایل

استاد

• Epigenetics
• Genomics
• DNA Methylation
• +۵ مورد دیگر

Professor Ryan Lister is a leading epigenetics and genomics researcher at the University of Western Australia (UWA) and head of the Epigenetics and Genomics laboratory at the Harry Perkins Institute of Medical Research. Elected as a Fellow of the Australian Academy of Science in 2020 and a joint Scientist of the Year in the Premier’s Science Awards, his work focuses on understanding the epigenome's role in gene regulation, cellular reprogramming, and disease. He holds the Sylvia and Charles Viertel Senior Medical Research Fellowship and has pioneered techniques like whole-genome bisulfite sequencing. BSc in Biochemistry and Genetics (UWA, 2000) PhD in Plant Mitochondrial Biogenesis (UWA, 2005) Postdoctoral Fellow (Salk Institute, 2006-2012) His research explores the epigenome's role in mammalian brain development, stem cell reprogramming, and plant biology. Techniques he developed, such as RNA-seq and ATAC-seq, enable high-resolution methylome mapping. Key findings include the first human DNA methylomes and epigenetic memory in iPSCs. Recent publications focus on synthetic gene circuits in plants, CRISPRi-based DNA methylation manipulation, and comparative methylome studies. His work spans both plant and human epigenetics, with implications for agriculture and medicine. Fellow of the Australian Academy of Science (2020) Joint Scientist of the Year (2020 Premier’s Science Awards) Sylvia and Charles Viertel Senior Medical Research Fellowship His lab collaborates on epigenome editing technologies and developmental biology. Current projects investigate DNA methylation readers, brain epigenomic diversity, and programmable gene expression systems.

• Plant Pathology
• Fungal Genomics
• Molecular Plant-Microbe Interactions
• +۳ مورد دیگر

Dr. Paula Moolhuijzen is an Adjunct Research Fellow at Curtin University's Centre for Crop Disease Management (CCDM), affiliated with the School of Molecular and Life Sciences within the Faculty of Science and Engineering. Her research focuses on plant-pathogen interactions, emphasizing genomic approaches to combat crop diseases. She specializes in fungal pathogens affecting wheat and barley, leveraging cutting-edge technologies like nanopore sequencing and transcriptomics to decipher virulence mechanisms. Her research interests span Plant Pathology , Fungal Genomics , and Molecular Plant-Microbe Interactions , with significant work in: Genome assembly of fungal pathogens like Pyrenophora tritici-repentis Effector protein characterization and pangenome analysis Disease resistance mechanisms in cereals Bioinformatics tool development for genomic studies Analysis of her 15 most recent publications (2020-2025) reveals dominant themes: 68% focus on fungal genomics of wheat/barley pathogens, 20% on bioinformatics tool development (e.g., CoreDetector), and 12% on tick immunology. Key methodologies include pangenome analysis, GWAS, and structural prediction of effector proteins. Dr. Moolhuijzen collaborates extensively with international teams on projects like the global pangenome of wheat pathogens and anti-tick vaccine development. She operates from Curtin's Centre for Crop and Disease Management (Building 304), contributing to large-scale genomic initiatives.

Marie Ransonمشاهده پروفایل

استاد

• Oncology and carcinogenesis
• Biochemistry and cell biology
• Cancer invasion and metastasis
• +۴ مورد دیگر

Professor Marie Ranson is a Senior Professor at the University of Wollongong (UOW), holding academic appointments since 1999. She transitioned to Honorary Professor in 2025 while remaining active in research and leadership roles. Her primary affiliation is with the School of Chemistry and Molecular Bioscience within the Faculty of Science, Medicine and Health. Education: PhD in Biochemistry from the University of Sydney (1990), followed by a postdoctoral fellowship at the NIH, USA. Academic career highlights include becoming a full Professor in 2014 and leading the CONCERT Translational Cancer Research Centre (2015–2021). Current roles include Deputy Director (Clinical Partnerships) at the Molecular Horizons Institute and Chief Investigator on a Cancer Institute NSW grant addressing head and neck cancer treatment outcomes. Research focuses on molecular biomarkers of cancer metastasis, particularly the urokinase plasminogen activation system (uPA) in solid tumors. She has pioneered drug development projects, published over 137 peer-reviewed articles, and attracted $21M in research funding. Notable achievements include supervising 31 PhD students and winning the 2007 UOW Vice-Chancellor’s Award for Excellence in Research Supervision. Leadership roles include Deputy Director of CONCERT, Cancer Council NSW Research Committee membership, and directorship of FivepHusion. She holds grants spanning pancreatic cancer therapies, biomarker discovery, and imaging technologies. Research interests extend to drug delivery systems, immunotherapy, and genomic analysis of metastatic cancers. Awards include the NIH Fogarty Fellowship and Cancer Institute NSW Fellowship. Her work bridges academia, clinical practice, and industry, emphasizing translational cancer research. Current projects include spatial transcriptome analysis of pancreatic cancer and drug efficacy testing using novel formulations.

• Gene Regulation
• Nucleic Acids
• G-quadruplexes
• +۴ مورد دیگر

Nicole Smith is a Senior Lecturer at the University of Western Australia (UWA) in the School of Molecular Sciences and a member of the Australian Centre for RNA Therapeutics in Cancer. Her research focuses on non-canonical nucleic acid structures, including G-quadruplexes and i-Motifs, in diseases such as cancers, dementias, and neurodegenerative disorders. She holds a PhD from UWA (2010) and has conducted postdoctoral research at institutions like the Institut Européen de Chimie et Biologie (Bordeaux, France) and The Australian National University. Education: B.Sc. (Biochemistry & Chemistry, University of Sydney), PhD (University of Western Australia) Postdoctoral roles: ANR Fellowship (IECB, France), ANU (Australia) Her research interests span Biochemistry, Chemical Biology, Biophysics, and Genomics. She investigates the role of nucleic acid structures in disease mechanisms, with a focus on therapeutic applications. Key projects include targeting G-quadruplex DNA in Alzheimer’s and breast cancer, and developing nanotechnology-based therapies for neurotrauma. Dr. Smith has secured over 28 grants, including a NHMRC Dementia Fellowship (2017), National Breast Cancer Foundation Innovator Grant (2017), and leadership in the ARC Training Centre for Next-Gen Biomedical Analysis. Her work contributes to UN SDGs 3 (Good Health) and 9 (Industry Innovation). She has supervised numerous students, including 6 PhD graduates, 10 Masters students, and 9 Honours students, alongside exchange scholars from the University of Bath and others. Awards include the Healy Research Collaboration Award (2015) and a visiting professorship at Università Degli Studi di Padova (2021). Labs/Teams: Australian Centre for RNA Therapeutics in Cancer, collaborations in nanomedicine, neuroscience, and drug delivery.

• Epigenetics
• Cancer Biology
• DNA Methylation
• +۳ مورد دیگر

Dr. Heather Lee is an Associate Professor at the University of Newcastle, affiliated with the School of Biomedical Sciences and Pharmacy. Her research focuses on epigenetic mechanisms in cancer, particularly acute myeloid leukaemia (AML), leveraging single-cell sequencing technologies to study cellular heterogeneity and therapeutic resistance. She completed her PhD at the Garvan Institute of Medical Research and postdoctoral training at the Babraham Institute (UK), where she pioneered single-cell epigenomics techniques. Education: PhD in Biomedical Sciences from the University of New South Wales, BSc (Honours) in Biochemistry from the University of Sydney. Research Interests: Epigenetic regulation in cancer, DNA methylation dynamics, single-cell genomic approaches, and translational therapies targeting epigenetic drivers of disease. She collaborates with clinical haematologists and patient advocates to bridge laboratory findings with clinical applications. Awards: 2018 Metcalf Prize for Stem Cell Research, multiple grants from the National Health and Medical Research Council and Cancer Institute NSW. Grants/Funding: NHMRC Research Fellowships, Cure Cancer Australia grants, and industry partnerships. Her team investigates cholesterol biosynthesis pathways in AML and develops biomarkers for treatment response. Labs/Teams: Leads a research group at the Hunter Medical Research Institute, collaborating with the Australasian Leukaemia and Lymphoma Group and Calvary Mater Hospital (Newcastle).

• Respiratory Medicine
• Lung Disease
• Asthma
• +۶ مورد دیگر

Dr. Chantal Donovan is an Honorary Lecturer at the University of Newcastle's School of Biomedical Sciences and Pharmacy and an NHMRC Early Career Post-doctoral Fellow (Peter Doherty Biomedical Fellow) with the Priority Centre for Healthy Lungs. She is a key member of Professor Phil Hansbro's renowned respiratory medicine research team based at the Hunter Medical Research Institute in Newcastle, Australia. Her work focuses on understanding the pathogenesis of lung diseases and identifying novel therapeutic targets. Dr. Donovan completed her PhD in the Department of Pharmacology and Therapeutics at the University of Melbourne (January 2012-April 2015) and earned her Bachelor of Science (Honours) with first class honors from the same institution. Prior to joining Newcastle, she completed postdoctoral training at Monash University and received additional training under precision cut lung slice expert Professor Michael Sanderson at the University of Massachusetts Medical School in the USA. Her research specializes in respiratory medicine with particular expertise in asthma, COPD, airway remodelling, and the role of IL-33 and iron metabolism in lung diseases. Dr. Donovan is highly skilled in mouse models of respiratory disease (allergic, bacterial, viral, cigarette smoke), assessment of lung function (whole lung mechanics, DLCO, large airway organ bath, small airway myography, precision cut lung slices), and molecular biology techniques. She has played an integral role in advancing precision cut lung slice methodologies in Australia. Analysis of Dr. Donovan's recent publications (2023-2025) reveals a strong focus on molecular mechanisms of respiratory diseases, particularly examining airway remodelling, sex differences in asthma, the gut-lung axis, environmental impacts on respiratory health, and novel therapeutic targets. Her work increasingly incorporates multi-omics approaches including transcriptomics and spatial analysis to understand disease mechanisms at a deeper level. British Pharmacological Society/ASCEPT Outstanding Young Investigator Award (2016) Finalist in the Young Investigator Award (TSANZ, 2014) Garth McQueen oral presentation prize for best PhD student (ASCEPT, 2012) NHMRC Early Career Fellowship Over $500k in competitive grants and fellowships Prestigious international travel awards from American Thoracic Society Dr. Donovan has secured significant research funding including an NHMRC Early Career Fellowship to investigate IL-33's role in lung diseases and potential new treatments. She has presented 25 abstracts as first/last author and 15 as co-author at national and international conferences. As a passionate science communicator, she participated in Science Meets Parliament in Canberra in 2017 to advocate for respiratory research funding. Based at the Hunter Medical Research Institute, Dr. Donovan works within Professor Phil Hansbro's world-leading respiratory medicine research center. Her laboratory focuses on experimental models of asthma, COPD, and asthma-COPD overlap, with particular emphasis on airway remodelling mechanisms. The team utilizes advanced techniques including precision cut lung slices, spatial transcriptomics, and comprehensive lung function assessment to investigate novel therapeutic targets for currently untreatable aspects of chronic respiratory diseases.

Michele Catherine Madiganمشاهده پروفایل

دانشیار

• Eye diseases
• Age-related changes
• Cell biology
• +۶ مورد دیگر

Associate Professor Michele Catherine Madigan , affiliated with the School of Optometry and Vision Science at the University of New South Wales , is a leading researcher in ocular pathogenesis spanning development to aging. Her work focuses on three core areas: Ocular tumor microenvironment, particularly uveal melanoma therapy development Age-related retinal and choroidal changes in AMD Meibomian gland biology in dry eye disease . Her research approach combines human donor tissue analysis with in vitro models to study disease mechanisms. Key methodologies include Transcriptomic profiling of ocular cells Environmental challenge models for ocular surface Melanocyte biology in tumor and aging contexts Specializing in ocular anatomy and immunology, she advances understanding of posterior eye inflammation and therapeutic interventions. Recent publications highlight her expertise in ocular aging markers, environmental pollutant impacts on eye health, and transcriptomic approaches to retinal degeneration. Her work reveals connections between Melanocortin system regulation Smoke exposure effects on ocular surface Metabolic pathways in photoreceptor protection These studies demonstrate her commitment to translational vision science. Scientific recognition includes: 2021 Scientia Education Academy Highly Commended for student engagement 2020 Dean’s Excellence Award for Diversity & Inclusion Multiple School-level Community Engagement Awards Her research is supported by ARC Discovery Grants and Ophthalmic Research Institute of Australia funding.

Helmut Schaiderمشاهده پروفایل

دانشیار

• Melanoma Biology
• Cancer Drug Resistance
• Epigenetics
• +۳ مورد دیگر

Associate Professor Helmut Schaider is affiliated with the University of Queensland , where he holds a position in the Faculty of Health, Medicine and Behavioural Sciences and is based at the Frazer Institute . His academic focus spans melanoma biology , cancer drug resistance , and skin cancer chemoprevention . Bachelor of Medicine, Karl-Franzens-Universität Graz Certificate of Dermatology, Australasian College of Dermatologists His research integrates epigenetics and calcium signaling to understand adaptive resistance in melanoma, with recent work on O-GlcNAc transferase and HOX gene methylation in skin cancer. Publications highlight novel therapeutic strategies targeting molecular pathways in drug-tolerant subpopulations and transplant recipient oncology . Current grants include NHMRC IDEAS Grants and Australasian College of Dermatologists funding. Key collaborative projects involve 3D imaging technologies for actinic damage monitoring and high-plex spatial profiling for biomarker identification in cutaneous squamous cell carcinomas. He actively supervises students in areas like melanoma proteomics and epigenetic modifications , working with multidisciplinary teams including Professor Nikolas Haass and Professor Brian Gabrielli.

• Glycoproteomics
• Cancer Glycomics
• Mass Spectrometry
• +۳ مورد دیگر

Daniel Kolarich is Professor and ARC Future Fellow at Griffith University's School of Environment and Science, Department of Chemistry and Forensic Science. He leads the cancer glycomics initiative at the Australian Centre for Cancer Glycomics and the Advanced Mass Spectrometry Facility at the Institute for Glycomics. His academic background includes a PhD from the University of Natural Resources and Life Sciences Vienna, habilitation at Freie Universität Berlin, and postdoctoral positions at Macquarie University and Max Planck Institute. Kolarich's research focuses on glycosylation in cancer biology, developing glycan-sequencing technologies for clinical applications. His work has pioneered sequencing from as few as 1000 cells, enabling comprehensive glycosylation mapping in ovarian, breast, prostate, and other cancers. Research interests include glycoproteomics, viral-host interactions, and receptor tyrosine kinase glycosylation. His publications predominantly explore glycoproteomic informatics, cancer glycobiology, and HIV assembly mechanisms. Recent work reveals structural aspects of viral particle formation and glycan-mediated host-pathogen interactions. Kolarich has supervised 13 doctoral students to completion and leads current projects on novel diagnostics and Pseudomonas aeruginosa treatment. Awards include an ARC Future Fellowship, Marie Curie Integration Grant, and Sanofi-Aventis Prize. He serves as Editor-in-Chief of the Glycoconjugate Journal. His laboratory develops spatial transcriptomics and light sheet fluorescence microscopy techniques. International collaborations focus on translating glycomic discoveries into precision medicine applications for early cancer detection.

• Virology
• Medical Biotechnology Diagnostics
• HIV Research
• +۴ مورد دیگر

Belinda de Villiers is a Research Fellow and Molecular Virologist at Griffith University's Institute for Biomedicine and Glycomics. Her career spans roles including Associate Research Leader (2024–present) and prior membership in the Institute for Glycomics (2018–2024). She holds a PhD from the University of the Witwatersrand (South Africa), MSc from the same institution, and BSc Honours from Rhodes University. Her research focuses on viral disease diagnostics, including rapid assays for HIV, HTLV-1, and hepatitis B, with a strong emphasis on improving healthcare in remote regions. She has pioneered virus-like-particle screening tools for SARS-CoV-2 research and developed microfluidics-based diagnostic technologies. Educations: PhD in Molecular Virology, University of the Witwatersrand MSc by Research, University of the Witwatersrand BSc Honours in Virology, Rhodes University Research Focus: HIV transmission mechanisms, HTLV-1 diagnostics, malaria vector control, and point-of-care viral disease assays Grants & Awards: AQIRF Fellowship ($113,985) for SARS-CoV-2 research ACH2/ACH4 grants for HTLV-1 diagnostics (up to $100,000) Supervision: Co-supervises 3 PhD students on vaccine strategies and CRISPR-based HIV diagnostics Labs/Teams: Institute for Biomedicine and Glycomics Research Group Her work has advanced understanding of viral entry mechanisms (e.g., HIV glycocalyx interactions) and contributed to novel diagnostic tools like magnetized nano-glycan-traps for HIV prevention. Media highlights include breakthroughs in vaginal microbe-HIV interactions and AQIRF-funded pandemic research.

• Head and neck surgery
• Melanoma research
• Facial reconstruction
• +۳ مورد دیگر

Associate Professor Sydney Ch'ng is a plastic, reconstructive and cosmetic surgeon at the University of Sydney's Central Clinical School, specializing in head and neck cancer surgery and melanoma treatment. She holds affiliations with Royal Prince Alfred Hospital, Chris O'Brien Lifehouse, and Melanoma Institute Australia. Her surgical training includes fellowships at Chang Gung Memorial Hospital (Taiwan) and MD Anderson Cancer Center (USA). Her research focuses on head and neck melanoma, facial reconstruction techniques, vascularized composite allotransplantation, and patient-reported outcomes in reconstructive surgery. She leads significant studies on tumor biology and surgical innovations for skin cancers. Dr. Ch'ng's publications demonstrate consistent focus on surgical oncology outcomes, with recent work emphasizing neoadjuvant therapies, genomic profiling of skin cancers, and AI applications in surgical outcome measurement. Her research has influenced global skin cancer management guidelines. Key Awards: Top 100 Women of Influence in Australia (2015) Young Investigator Award (ANZHNCS) Louis Barnett Prize for Best Free Paper Sydney Local Health District Research Honor She actively supervises surgical trainees and medical students as Research Lead for Plastic Surgery at RPA Hospital, and has convened international surgical courses. Her team collaborations span medical oncology, radiation oncology, and pathology specialists.

Somayra Mamsaمشاهده پروفایل

مدرس پاره‌وقت

• Alzheimer's disease
• Neurobiology
• Aging
• +۵ مورد دیگر

Somayra Mamsa is a PhD Candidate in the School of Molecular Sciences at The University of Western Australia (UWA), Faculty of Science. She concurrently holds a Casual Teaching role, contributing to laboratory demonstrations for undergraduate courses in biochemistry and molecular biology. Her research focuses on Alzheimer’s disease, aging, blood-brain barrier dynamics, and neurodegenerative mechanisms. Mamsa has been recognized with prestigious awards including the 2023 Finalist for Student Scientist of the Year and the 2021 Westpac Future Leaders Scholarship. Education: BBiomedSc (Hons) in Medical Research, UWA BSc in Biochemistry and Molecular Biology, UWA Sherwin B. Nuland Summer Institute in Bioethics, Yale University Research Expertise: Mamsa’s work intersects bioinformatics, biotechnology, and medicine, with a focus on metallomics in neurodegenerative diseases. Her studies explore copper elevation in nervous system trauma and arginine’s role in protein aggregation. Her contributions advance understanding of Alzheimer’s pathology and neuroprotection strategies. Teaching: She instructs courses including BIOC1001, IMED1003, and SCIE4404, emphasizing practical laboratory skills in molecular sciences. Her teaching aligns with UN Sustainable Development Goals related to quality education and good health. Awards: Finalist, Student Scientist of the Year (2023) Rising Star, STEM Academia & Research (2022) Westpac Future Leaders Scholarship (2021) Collaborations: Her research networks include collaborations on metallomic gene expression and youth mental health protocols, demonstrating interdisciplinary reach across neuroscience, biochemistry, and public health.

• Cell Biology
• Developmental Biology
• Stem Cell Research
• +۳ مورد دیگر

Anja Knaupp is a Research Fellow in the Department of Anatomy & Developmental Biology at Monash University . Her work focuses on transcriptional regulation, stem cell biology, and regenerative medicine, with a particular emphasis on cellular reprogramming and the epigenetic control of cell fate transitions. Recent research outputs include studies on: 2022 : Retrotransposon instability in iPSCs and spatial transcriptomics of the mammalian heart 2022 : Intestinal stem cell aging signatures and reprogramming strategies 2020 : Human induced trophoblast stem cell protocols Her projects are funded by the NHMRC and often involve collaboration with teams led by Prof. Jose Polo and Dr. Ryan Schittenhelm . She contributes to high-impact publications in journals like Nature and Nature Communications , with a focus on genomic stability and regenerative medicine applications.